EG 427 appoints Ralph Laufer as new member to Board of Directors
May 09, 2023Biotech and pharmaceutical industry veteran, Ralph Laufer, Ph.D., joins the Board of Directors as an independent member.
EG 427 is adding complementary expertise among its Board directors to support its ambitions.
Read full Press Release in English or in French